| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2639850682505aff29646d717e8759fb |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G09B23-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-178 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G09B23-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-178 |
| filingDate |
2018-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2019-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fcd66bbc01c284452368c79a3d8eb2a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea9b84365d60f944a7d9ef2a94783efc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84164317158711d89eb6a439ff752000
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc80cd5d8a8b485ce14cc3d6ab328225
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4692849b1dc6d19e1027989301972bc0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d91e91a7287af6b0b5ead1b533b55ffa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_692a52a76c2a7d8d642a58bd580ef586
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80f8d133fafec773ee59d581f79e026d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9cccf30a7c6e8a2d258cb4c07705e52c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7db7677d7a5a4530578c2e4d2fd62bd5 |
| publicationDate |
2019-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2701218-C1 |
| titleOfInvention |
Method for modeling acute emotional immobilization stress in experiment |
| abstract |
FIELD: medicine. n SUBSTANCE: invention refers to medicine, namely to psychology and psychophysiology, and can be used to model acute emotional immobilization stress in experiment. That is ensured by immobilizing an animal. Then adrenalin 25 mcg/kg is injected intraperitoneally twice every 3 hours with the duration of immobilization after the first adrenaline introduction for 6 hours. n EFFECT: method provides pathogenetically and psychophysiologically based modeling of emotional immobilization stress in experiment by increasing the emotional response to the background of immobilization of the experimental animal. n 1 cl |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2755932-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2767919-C1 |
| priorityDate |
2018-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |